Corteva (CTVA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Mar, 2026Executive summary
Annual meeting scheduled for April 28, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote on key proposals before April 27, 2026.
Voting matters and shareholder proposals
Election of 12 directors is on the ballot, with all nominees recommended by the board.
Advisory vote on executive compensation for named executive officers is included.
Advisory vote on the frequency of future say-on-pay votes, with a recommendation for annual votes.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026 is proposed.
Provision for transaction of any other business that may properly come before the meeting.
Board of directors and corporate governance
Twelve director nominees are listed for election, reflecting board continuity and governance priorities.
Latest events from Corteva
- 2025 outlook targets double-digit EBITDA growth and margin expansion, led by cost savings and innovation.CTVA
Q3 20249 Jul 2026 - Seed strength and margin gains offset Crop Protection headwinds; 2024 outlook trimmed.CTVA
Q2 20248 Jul 2026 - 2025 guidance targets 10% EBITDA growth and margin expansion amid strong segment momentum.CTVA
Q4 20248 Jul 2026 - EU gene editing approval and innovation in seeds and AI set the stage for long-term growth.CTVA
Wolfe Research 3rd Annual Materials of the Future Conference 202617 Jun 2026 - Six growth platforms and innovation target $4.4B EBITDA, 23–25% margins, and $4.5B returns by 2027.CTVA
Investor Day 202426 May 2026 - Separation on track as innovation and licensing drive growth in seed and crop protection.CTVA
21st Annual Global Farm to Market Conference14 May 2026 - Q1 2026 delivered double-digit sales and EBITDA growth, margin gains, and strategic progress.CTVA
Q1 20266 May 2026 - Strong financials, leadership changes, and all proposals approved amid strategic separation plans.CTVA
AGM 202629 Apr 2026 - 2025 saw record EBITDA and cash flow; 2026 outlook targets 7% EBITDA growth and separation.CTVA
Q4 202517 Apr 2026